#pharmaceutical2 articles

2 articles

AIBullisharXiv – CS AI · 5h ago

🧠

Mozi: Governed Autonomy for Drug Discovery LLM Agents

Researchers have introduced Mozi, a dual-layer architecture designed to make AI agents more reliable for drug discovery by implementing governance controls and structured workflows. The system addresses critical issues of unconstrained tool use and poor long-term reliability that have limited LLM deployment in pharmaceutical research.

AIBullisharXiv – CS AI · 5h ago

🧠

MMAI Gym for Science: Training Liquid Foundation Models for Drug Discovery

Researchers introduce MMAI Gym for Science, a training framework for molecular foundation models in drug discovery. Their Liquid Foundation Model (LFM) outperforms larger general-purpose models on drug discovery tasks while being more efficient and specialized for molecular applications.